Li Yan, Jiang Hui, Ruan Chengchao, Zhong Jiuchang, Gao Pingjin, Zhu Dingliang, Niu Wenquan, Guo Shujie
State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Laboratory of Vascular Biology, Institute of Health Sciences, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Hypertens Res. 2014 Jan;37(1):35-42. doi: 10.1038/hr.2013.110. Epub 2013 Sep 12.
Transient receptor potential melastatin 7 (TRPM7), a novel channel kinase, has been recently identified in the vasculature. However, its regulation and function in vascular diseases remain poorly understood. To address this lack of knowledge, we sought to examine whether TRPM7 can mediate the vascular remodeling process induced by pressure overload in the right common carotid artery proximal to the band (RCCA-B) in male Sprague-Dawley rats with transverse aortic constriction (TAC). The contribution of TRPM7 to amplified vascular remodeling after TAC was tested using morphometric and western blot analyses. Pressure overload-induced vascular wall thickening, especially in the adventitia, was readily detected in RCCA-B. The TRPM7 level was increased with a simultaneous accumulation of macrophages in the adventitia of RCCA-B, whereas the anti-inflammatory molecule annexin-1, a TRPM7 downstream target, was decreased. After the addition of the TRPM7 inhibitor 2-aminoethoxydiphenyl borate (2-APB), significant reductions in macrophage accumulation as well as the expression of monocyte chemotactic protein-1, SM-22-α and collagen I were observed, whereas annexin-1 was rescued. Finally, in cultured vascular adventitial fibroblasts treated with macrophage-conditioned medium, there were marked increases in the expression of TRPM7 and SM-22-α with a concurrent reduction in annexin-1 expression; these effects were largely prevented by treatment with 2-APB and specific anti-TRPM7 small interfering RNA. Our findings provide the first demonstration of the potential regulatory roles of TRPM7 in the vascular inflammation, pressure overload-mediated vascular adventitial collagen accumulation and cell phenotypic transformation in TAC rats. The targeting of TRPM7 has potential therapeutic importance for vascular diseases.
瞬时受体电位褪黑素7(TRPM7)是一种新型的通道激酶,最近在脉管系统中被发现。然而,其在血管疾病中的调节和功能仍知之甚少。为了解决这一知识空白,我们试图研究TRPM7是否能介导雄性Sprague-Dawley大鼠经主动脉缩窄(TAC)后,右侧颈总动脉近端束带处(RCCA-B)压力过载诱导的血管重塑过程。使用形态计量学和蛋白质印迹分析测试了TRPM7对TAC后血管重塑增强的作用。在RCCA-B中很容易检测到压力过载诱导的血管壁增厚,尤其是在外膜。TRPM7水平升高,同时RCCA-B外膜中的巨噬细胞积聚,而抗炎分子膜联蛋白-1(TRPM7的下游靶点)减少。添加TRPM7抑制剂2-氨基乙氧基二苯硼酸盐(2-APB)后,观察到巨噬细胞积聚以及单核细胞趋化蛋白-1、SM-22-α和I型胶原的表达显著降低,而膜联蛋白-1得到挽救。最后,在用巨噬细胞条件培养基处理的培养血管外膜成纤维细胞中,TRPM7和SM-22-α的表达显著增加,同时膜联蛋白-1的表达降低;用2-APB和特异性抗TRPM7小干扰RNA处理可在很大程度上阻止这些效应。我们的研究结果首次证明了TRPM7在TAC大鼠血管炎症、压力过载介导的血管外膜胶原积聚和细胞表型转化中的潜在调节作用。靶向TRPM7对血管疾病具有潜在的治疗意义。